Kaizen Advisory’s Phibro Animal Health PAHC Stock Holding History

Kaizen Advisory’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-26,060	Closed	-$873K	–	613
2017 Q4	$873K	Buy	+26,060	New	+$925K	0.52%	88

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FIM

Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return

CVA

Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CRCP

Copper Rock Capital Partners Boston, Massachusetts $296M AUM 28.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DIA

Denver Investment Advisors Denver, Colorado $1.89B AUM 7.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Kaizen Advisory's PAHC Position: Q1 2018 in Review

Kaizen Advisory sold out of Phibro Animal Health (PAHC) in Q1 2018, closing a stake of 26,060 shares — an estimated $873K sold.

Kaizen Advisory first reported a position in PAHC in Q4 2017 and held it in 1 quarter. The position peaked at $873K in Q4 2017. 171 funds tracked by Wall St. Rank hold PAHC as of Q1 2018.

Kaizen Advisory reported no remaining Phibro Animal Health position as of Q1 2018 after selling out during the quarter.
Kaizen Advisory sold 26,060 Phibro Animal Health shares in Q1 2018, an estimated $873K.
Kaizen Advisory first reported a position in Phibro Animal Health in Q4 2017 and held it in 1 quarter.
Kaizen Advisory's Phibro Animal Health position peaked at $873K in Q4 2017.
171 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2018.

Based on Kaizen Advisory's 13F filing for Q1 2018, filed 15 May 2018.